Table 1.
Intermediate Prognosis | |
subtype | successes/trials |
Leiomyosarcoma | 6/28 |
Liposarcoma | 7/29 |
MFH | 3/29 |
Osteosarcoma | 5/26 |
Synovial | 3/20 |
Angiosarcoma | 2/15 |
MPNST | 1/5 |
Fibrosarcoma | 1/12 |
Good Prognosis | |
Ewing’s | 0/13 |
Rhabdo | 0/2 |
Intermediate Prognosis | |
subtype | successes/trials |
Leiomyosarcoma | 6/28 |
Liposarcoma | 7/29 |
MFH | 3/29 |
Osteosarcoma | 5/26 |
Synovial | 3/20 |
Angiosarcoma | 2/15 |
MPNST | 1/5 |
Fibrosarcoma | 1/12 |
Good Prognosis | |
Ewing’s | 0/13 |
Rhabdo | 0/2 |